Fundraising Fox

Wysa

Founded 2015 Β· 180 employees on LinkedIn Β· 4 known investors

Wysa is an AI-powered digital mental health platform that provides clinically backed behavioral health support through chatbot conversations and guided referrals for individuals, employers, and health systems. The platform operates anonymously and is designed to integrate with care models, offering support from initial engagement through ongoing follow-up care.

Also known as Touchkin Β· Wysa (Touchkin eServices)

Founders & leadership

Wysa was founded in 2015 by Jo Aggarwal and Ramakant Vempati.

JA
Jo AggarwalinFounder
RV
Ramakant VempatiinFounder

Investors Β· 4

Also in the syndicate Β· 2

Google Assistant Investment ProgramW Health Ventureslead

Company profile

researched Aug 2026

Wysa operates an AI-powered mental health application available on Android, iOS and the web for self-help and self-monitoring of emotional wellbeing. Its conversational agent combines rule-based algorithms with large language models to respond to users' expressed thoughts and emotions, and directs them to a library of evidence-based exercises drawn from cognitive behavioural therapy, solution-focused therapy and mindfulness, including breathing exercises, meditation, sleep sounds and thought-reframing tools. The app is intended for users aged 13 and over (11+ where agreed with an institutional partner), is not positioned as a substitute for professional medical advice, and is not recommended for crisis situations or for people with severe and enduring mental health problems.

Beyond the self-help app, Wysa offers a tiered model: free AI chat; structured human support from coaches, counsellors and therapists on staff; and clinical programmes. Coaches hold a master's degree in psychology or social work plus a coaching certification and deliver text-based or audio-video sessions with asynchronous messaging between sessions. Institutional versions of the product are deployed by employers, schools, universities and insurers, and the company markets modules for healthcare settings including children and young people, collaborative care (CoCM), physical therapy and NHS Talking Therapies, plus insurer-facing offerings and product lines branded Gateway, Navigator, Copilot and AI Self-Help.

Wysa's stack runs on AWS with MongoDB Atlas, Cloudflare and Firebase/Google Analytics, uses Private AI to screen personal details from conversation data, and provisions generative AI features through OpenAI, Anthropic and Google Gemini models alongside Wysa's own proprietary AI, with US or UK data residency depending on the client. Translation services (Microsoft Azure Translator, Google Translate, DeepL) support multilingual conversation modules, and Twilio and Turn.io enable delivery of the conversation space over WhatsApp.

Founding story

Wysa was conceptualized in 2016 after co-founder and CEO Jo Aggarwal experienced a period of deep depression; the company was started with a mission to provide low-cost emotional wellness support globally, addressing the gap between demand for mental health care and the limited supply of trained professionals. Aggarwal previously served as founding director for technology and innovation at a UN-backed foundation and as managing director of Pearson Learning Solutions in the UK.

Business model

Wysa sells through both consumer and institutional channels. The core AI chat and in-conversation tools are free, with a paid premium tier that unlocks a wider tool library and one-on-one coaching sessions, offered in weekly, monthly and quarterly subscription packs. Institutional partners β€” employers, schools, universities, insurers and health systems β€” license versions of Wysa and provide premium access to their populations at no cost to the end user, sometimes including human coaching. As of 2022, about 80% of Wysa's business came from enterprise customers, with the B2C model having historically driven most of its reach.

Freemium consumer subscriptions for premium tools and coaching, plus enterprise and institutional licensing to employers (via employee assistance programmes), insurers, healthcare providers and government health authorities. Premium human coaching is offered at additional cost in some locations. Grant funding also supports specific programmes.

Traction

Company figures cite over 6 million users, 11 million lives covered, 105 countries, 1 billion AI conversations, 45+ peer-reviewed publications, 91% of users finding Wysa helpful, 10x access to mental health support and a 33% reduction in lost-time days. At the time of its 2022 Series B, Wysa reported 4.5 million users across 65 countries and more than 400 million conversations. A 2023 profile cited 550 million conversations with 6.5 million users in 95 countries. A peer-reviewed JMIR study of 1,213 Wysa users found those with app access between coaching sessions averaged 6.57 sessions versus 0.55 for coaching alone, making them nearly three times more likely to complete their coaching programme.

Latest developments

Wellcome has awarded Wysa a Β£5.3 million grant for a scale-up study adapting a clinically validated digital mental health intervention for adolescent girls in rural India. Wysa launched Dreamkit in Maharashtra, a combined physical-workbook and digital programme delivered in Marathi for adolescent girls in low-resource settings, and released multilingual capabilities. It was named a Top 10 winner in the AI for All: Global Impact Challenge at the India AI Impact Summit 2026, selected from more than 1,350 applications across 60 countries, and was cited by Senior Minister of State for Health Dr Poh-Koon Koh in Singapore's Parliament for powering mindline.sg. Kins is now part of Wysa, extending the platform into virtual physical therapy, and Wysa has partnered with April Health to deliver collaborative care in primary care practices. A peer-reviewed JMIR study reported that AI support between coaching sessions nearly tripled coaching programme completion.

β–ΈFull profile β€” market position, technology, go-to-market, geography, history, risks & controversies

Market position

Positioned as an evidence-based, clinically governed alternative to general-purpose AI chatbots for behavioral health, spanning early engagement through ongoing follow-up care. Wysa holds FDA Breakthrough Device Designation (May 2022) and an AI Award from the UK's NHS, and is used within NHS online mental health services and by Singapore's Ministry of Health. It cites 45+ peer-reviewed publications and 11 million lives covered across 105 countries.

Wysa emphasises anonymous, stigma-free access with no appointments or waiting; human oversight in every care pathway; AI that does not make autonomous decisions and is described as explainable and defensible within clinical workflows; clinically approved and tested content; and regulatory and health-system recognition (FDA Breakthrough Device Designation, NHS AI Award). Its institutional versions can be configured as rule-based only, and it offers US or UK data residency for specific clients.

Technology

A conversational agent combining proprietary rule-based algorithms with large language models; different institutional deployments use rule-based-only or hybrid rule-based/LLM experiences. Generative AI features draw on OpenAI, Anthropic and Google Gemini models alongside Wysa's own AI, with conversation data screened by Private AI for inadvertently shared personal details. The company states its AI never makes decisions on its own and that all care pathways include human oversight. Infrastructure runs on AWS and MongoDB Atlas with US or UK data residency options; translation APIs (Azure Translator, Google Translate, DeepL) support multilingual modules and Twilio/Turn.io deliver the service over WhatsApp. The company has published on architecting zero-downtime operations at roughly 1.5 million requests per quarter.

Go-to-market

Wysa reaches consumers directly through its free app and premium subscriptions, and sells business-to-business to employers, insurers and health systems, positioning modules for specific care settings such as collaborative care in primary care, physical therapy, NHS Talking Therapies and children and young people's services. It publishes peer-reviewed clinical evidence, case studies and reports to support enterprise sales, and works through partnerships β€” for example powering mindline.sg in Singapore, joining forces with April Health for CoCM delivery in US primary care practices, and integrating Kins for virtual physical therapy. It has participated in accelerator and platform programmes including the Google Investment Programme, the DigitalHealth.London Accelerator and an AWS accelerator in the UK.

Individuals aged 13 and over experiencing low mood, stress or anxiety or seeking to build emotional resilience; employers and their employee benefits/EAP programmes; schools and universities; insurers; and healthcare providers and public health authorities. Named customers and deployments include Aetna International, Accenture, Colgate-Palmolive, Swiss Re, the UK NHS, Cincinnati Children's Hospital Medical Center and Singapore's Ministry of Health.

Geography

Operations in Bengaluru, India; Boston, Massachusetts; and London, UK, with the founder and CEO based in Boston. Services are used in over 100 countries, with focus markets in India, the United States and the United Kingdom, and deployments in Singapore. Data is processed in the USA, UK, Europe and India depending on the service and client.

History

Originally founded in India around an AI chatbot for talking through feelings, Wysa expanded into a broader set of mental health services. It raised early seed capital in 2016 and 2017, further seed funding in 2019, a $5.5 million Series A in 2021 led by W Health Ventures with the Google Assistant Investment Program, pi Ventures and Kae Capital, and a $20 million Series B in July 2022 led by HealthQuad with British International Investment. It joined the Google Investment Programme in 2021 as one of 17 selected apps and received FDA Breakthrough Device Designation in May 2022. Subsequent developments include multilingual capabilities, a Wellcome Trust grant, the Dreamkit programme in rural India, integration with Kins for physical therapy, and a partnership with April Health for collaborative care.

Risks & controversies

Wysa states its app is not a substitute for professional medical advice, does not provide diagnoses, and is not suitable for crisis situations or for people with severe and enduring mental health problems. Its FDA Breakthrough Device Designation is not clearance to prescribe Wysa as a medical solution. The sector faces privacy scrutiny β€” a Mozilla report singled out some of Wysa's competitors for lax privacy practices β€” and regulatory attention, with US states moving to regulate AI chatbots and the American Psychological Association warning against AI therapy. Wysa relies on third-party LLM providers and cloud vendors for parts of its service.

Compiled by commissioned research from 8 cited public sources β€” announcements, filings, and press listed under research sources below.

Key figures

latest reported
AI conversationsJan 20261,000,000,000 conversations
AI request volumeJan 20261,500,000 requests per quarter
Average coaching sessions completed with app accessJan 20266.6 sessions
ConversationsJan 2023550,000,000 conversations
Conversations servedJul 2022400,000,000 conversations
Countries servedJan 2026105
Employee countJan 2026183 employees
Glassdoor ratingJan 20263.5 out of 5 (67 reviews)
HeadcountAug 2026180
HeadcountJul 2022100-150 people
Lives coveredJan 202611,000,000 lives
Peer-reviewed publicationsJan 202645 publications
Reduction in lost-time daysJan 202633%
Share of revenue from enterprise customersJul 202280%
Total funding raised prior to Series BJul 2022$9.4M
UsersJan 20266,000,000 users

Company-reported or press-reported figures, each dated to when it was claimed β€” not independently audited.

Competitors Β· 7

by search overlap
Psychcentral942 shared keywordsPsych Central is a mental health information website providing content and products for informational purposes. It is operated by Healthline Media, an RVO Health company.
Choosing Therapy761 shared keywords
Talkspace634 shared keywordsTalkspace is an online mental health care platform that provides research-backed therapy and psychiatric services covered by insurance, allowing users to connect with licensed therapists and psychiatrists through text, audio, or video.
Charlie Health460 shared keywordsCharlie Health is a virtual provider of high-acuity behavioral healthcare, delivering personalized, evidence-based treatment programs that combine licensed clinicians, peer connection, and family involvement. It serves individuals and families in the U.S. facing serious mental health and substance use challenges, with a focus on young people.
BetterUp459 shared keywordsBetterUp provides an AI-powered coaching and professional development platform that helps organizations support employee growth and wellbeing. The platform serves enterprises and their employees through behavioral science-backed coaching and talent management tools.
Thriveworks445 shared keywordsThriveworks provides therapy and psychiatric medication management services, helping clients find providers and book sessions, with insurance accepted. It operates a network of over 2,000 clinicians offering mental health care.
Calm405 shared keywordsCalm is a mental health app offering guided meditations, sleep stories, soundscapes, and stress-relief tools designed to help users manage anxiety, improve sleep, and build healthy habits for overall wellness.

Companies competing with Wysa for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline Β· 12

launches, deals, and filings
Jan 2026
Kins becomes part of Wysa

Kins, which delivers licensed-clinician physical therapy outside the clinic, is now part of Wysa, extending the platform across physical and mental health care pathways.

source β†—

Jan 2026
Top 10 winner, AI for All Global Impact Challenge at India AI Impact Summit 2026

Selected from more than 1,350 applications across 60 countries in the AI for All category.

source β†—

Jan 2026
Wellcome awards Β£5.3 million grant to Wysa

Wellcome awarded Β£5.3 million to fund a scale-up study adapting a clinically validated digital mental health intervention for adolescent girls in rural India.

source β†—

Jan 2026
Wysa cited in Singapore Parliament

Senior Minister of State for Health Dr Poh-Koon Koh cited Wysa in Singapore's Parliament during a debate on digital mental health support for teenagers and young adults; Wysa powers mindline.sg, providing 24/7 CBT-based support.

source β†—

Jan 2026
Partnership with April Health for Collaborative Care Model delivery

Wysa joined forces with April Health to help US primary care practices deliver integrated behavioral health care through CoCM, with every referral receiving AI support regardless of insurance status.

source β†—

Jan 2026
Wysa launches Dreamkit in rural Maharashtra

Dreamkit combines physical workbooks with clinically backed digital tools for adolescent girls in rural India, co-designed with local partners and delivered in Marathi.

source β†—

Jan 2026
Wysa launches multilingual capabilities

Wysa introduced multilingual capabilities to broaden access to mental health support globally.

source β†—

Jul 2022
Wysa raises $20M Series B led by HealthQuad

All-equity Series B of $20 million led by HealthQuad with participation from British International Investment, to expand in India, the US and the UK and widen multilingual support. Prior to this round Wysa had raised $9.4 million; valuation not disclosed.

$20M source β†—

May 2022
FDA Breakthrough Device Designation

Wysa received Breakthrough Device Designation from the US Food and Drug Administration; the designation is not clearance to prescribe Wysa as a medical solution.

source β†—

Jan 2022
Jo Aggarwal named a World Economic Forum Top Innovator of 2022

Co-founder and CEO Jo Aggarwal was recognised by the World Economic Forum as one of the Top Innovators of 2022 and, with co-founder Ramakant Vempati, received the 2022 eMHIC Implementation Leadership Award for the USA.

source β†—

Mar 2021
Wysa raises $5.5M Series A led by W Health Ventures

Series A round led by Boston-based W Health Ventures, including the Google Assistant Investment Program, pi Ventures and Kae Capital.

$5.5M source β†—

Mar 2021
Selected for Google Investment Programme

Wysa became one of 17 apps included in the Google Investment Programme.

source β†—

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

β–ΈResearch sources Β· 8

primary sources listed
  • Wysawysa.io Β· web

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Wysa do?
Wysa is an AI conversational mental health platform offering anonymous, CBT-based support for individuals, employers and health systems.
Who founded Wysa?
Wysa was founded by Jo Aggarwal, Ramakant Vempati in 2015.
Who are Wysa's investors?
Wysa's investors include Kae Capital, HealthQuad.